OrbiMed Advisors Discloses Investment at Yarrow Bioscience with 9.97% StakeTradingView·11 hours agoYARW-67.00%VYNE0.00%
Biotech Stocks At 52-Week Highs - ANGO, ANIK, ELOX, YARW, PLSErttnews·2 days ago, 03:20 AMANGO-99.00%ELOX-298.00%
This Charles Schwab Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Mondaybenzinga_article·2 days ago, 09:24 AMYARW-67.00%SCHW+157.00%
Why SAP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarketbenzinga_article·Jul 24 at 03:35 AMAMKR-360.00%LVWR-1268.00%
Vyne Therapeutics set for 1-for-50 reverse stock split on July 24PUBT·Jul 23 at 03:50 PMVYNE0.00%YARW-67.00%
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience | VYNE Stock NewsStockTitan·Jul 23 at 07:26 AMVYNE0.00%YARW-67.00%
VYNE Therapeutics Sets 1-for-50 Reverse Stock Split Ahead Of Yarrow Mergerrttnews·Jul 21 at 07:35 AMVYNE0.00%YARW-67.00%
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·Jul 21 at 07:05 AMZYBT+8438.00%IMNN-479.00%
Vyne Therapeutics holds shareholder special meeting on merger proposalsPUBT·Jul 20 at 05:04 AMVYNE0.00%YARW-67.00%
VYNE: YB-101 targets unmet needs in GD and TED with a novel, well-funded, and differentiated approachQuartr·Jul 14 at 05:05 PMVYNE0.00%YARW-67.00%
VYNE Therapeutics declares $0.38/share merger-contingent special dividendbusinessinsider·Jul 13 at 12:00 AMVYNE0.00%YARW-67.00%
